Rui Gao

Title: Rui Gao - Innovator in Tumor Chemotherapy Detection

Introduction

Rui Gao is a prominent inventor based in Guiyang, China. He has made significant contributions to the field of medical diagnostics, particularly in the detection of circulating tumor DNA (ctDNA) and drug-resistant genes. His innovative work aims to enhance the applicability of tumor chemotherapeutic drugs.

Latest Patents

Rui Gao holds a patent for a "Kit for detecting ctDNA and expression of drug-resistant genes related to applicability of tumor chemotherapeutic drugs." This kit provides a method for determining ctDNA concentration by dissolving extracted ctDNA in Tris-HCl buffer with a pH greater than 7.0. The process involves adding 2,7-bis(1-methyl-4-vinylpyridine)-9-ethylcarbazole iodised salt as a molecular probe. The concentration of ctDNA in the solution is calculated by measuring the fluorescence intensity, demonstrating extremely high sensitivity in determining ctDNA concentrations ranging from 0 µg/ml to 50 µg/ml.

Career Highlights

Rui Gao's career is marked by his dedication to advancing cancer treatment methodologies. His innovative approach to ctDNA detection has the potential to significantly impact the effectiveness of chemotherapy treatments. With a focus on precision and sensitivity, his work is paving the way for more personalized cancer therapies.

Collaborations

Rui Gao has collaborated with notable colleagues, including Shi Zhou and Zhi Xiong Huang. Their combined expertise contributes to the advancement of research in the field of tumor diagnostics.

Conclusion

Rui Gao's contributions to the field of medical diagnostics, particularly in the detection of ctDNA, highlight his role as an innovator in cancer treatment. His patented methods and collaborative efforts are set to make a lasting impact on the effectiveness of chemotherapy drugs.